ArticleJournal of gastrointestinal oncology2021

Urokinase plasminogen activator predicts poor prognosis in hepatocellular carcinoma.

Fei-Yu Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.